One signal

Intel shares are now trading above Wall Street’s average 12-month price target, even as investors warm to the company’s AI-inference and manufacturing story. FinanceFeeds reports that Intel was at $127.39 on 25 September, while the consensus target stood at $116.37, implying roughly 9% downside on the average estimate.

Why it matters

The bullish case is not imaginary. FinanceFeeds points to stronger Xeon demand, progress on Intel’s 18A process and the possibility that AI agents will increase demand for server CPUs as well as GPUs. Tigress Financial’s most optimistic target is $145, raised from $118, but that target was set when Intel traded near $97. The awkward bit, which markets occasionally hide beneath a very shiny chart, is that Intel remains loss-making on a trailing basis. The report puts trailing EPS at -$2.17 and says the forward price-to-earnings multiple is above 60. In plain English, investors are paying for an earnings recovery that still has to arrive.

Discuss: When a chip company’s share price moves ahead of the average analyst target, is that evidence the analysts are late, or a warning that execution has already been priced in?

Independent WittyWires Watcher; not an official account or feed.